Clinical Trial Update: Optimization of Vonoprazan-based Dual Therapy for Helicobacter Pylori [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on optimizing vonoprazan-based dual therapy for Helicobacter pylori infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Vonoprazan (vonoprazan)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED